Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ANIP | Common Stock | Sale | -$278K | -5K | -0.54% | $55.63 | 928K | Jan 16, 2024 | Held by Esjay LLC | F1, F2, F3 |
transaction | ANIP | Common Stock | Sale | -$551K | -10K | -1.08% | $55.11 | 918K | Jan 17, 2024 | Held by Esjay LLC | F1, F3, F4 |
transaction | ANIP | Common Stock | Sale | -$541K | -9.78K | -1.07% | $55.30 | 908K | Jan 18, 2024 | Held by Esjay LLC | F1, F3, F5 |
holding | ANIP | Common Stock | 47.4K | Jan 16, 2024 | Direct | ||||||
holding | ANIP | Common Stock | 5K | Jan 16, 2024 | Held by SS Pharma LLC | F6 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.99 to $56.71, inclusive. |
F3 | The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.59 to $55.57, inclusive. |
F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.70 to $55.73, inclusive. |
F6 | The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. |